Pinned Tweet
PANTS - Maximising patient data and samples + fantastic collaboration
Recruitment March 2013- July 2016
PANTS - FACTS
👥 1600+ patients
🩺13900 patient visits
🏥118 NHS Hospitals
👩💻300 NHS research staff
🧪~90000 frozen samples
💩~6000 poo samples
@tariqahmadIBD
RAPIDIBD retweeted
Free e-learning resources are available for health and care researchers to help develop your leadership skills. Log in or register on NIHR Learn and select Leadership Development and then Leadership e-learning modules to find out more: learn.nihr.ac.uk/course/view…
No9
Baseline TREM-1 Whole Blood Gene Expression Does Not Predict Response to Adalimumab Treatment in Patients with Ulcerative Colitis or Crohn’s Disease in the SERENE Studies academic.oup.com/ecco-jcc/ar…
@SeverineVermei1 @bverstockt
1
2
179
No10 !! 3 YR
Mechanisms and management of loss of response to anti-TNF therapy for patients with Crohn's disease: 3-year data from the prospective, multicentre PANTS cohort study -thelancet.com/journals/langa…
@ibdseb @charlie_lees @exeteribdresea1
Watch this space
RAPIDIBD retweeted
Week 2 @NIHRresearch.
✅84 🏥 in set up.
✅30 🏥 ready to 🟢!
✅52 patients recruited.
✅ 3500 patient packs sent.
Active #IBDresearch collaborations in 🏴 🏴 🏴
RAPIDIBD retweeted
Genetic variant influences anti-TNF immunogenicity in Crohn’s healio.com/gastroenterology/… HLA-DQA1*05 essentially doubles the rate of immunogenicity @HealioGastro @AGA_Gastro
RAPIDIBD retweeted
The main treatment for #Crohns disease is a TNF-antibody, but many patients develop an immune response. It turns out that a common HLA allele (40% w/ European ancestry) is tied to this problem gastrojournal.org/article/S0… @AGA_Gastro @AmerGastroAssn #PGX
RAPIDIBD retweeted
Our #GWAS of immunogenicity to anti-TNF in #Crohns has just gone online at @AGA_Gastro. Thanks to all the patients, PIs, nurses and the hard work of the @PANTSresearch team led by @tariqahmadIBD and @anderson_carl's group at @sangerinstitute! gastrojournal.org/article/S0…
RAPIDIBD retweeted
This is @PANTSresearch - collaborative UK IBD research at its best. Led tirelessly by @tariqahmadIBD + @ClaireBewshea ... driven by @DrNickKennedy + @alehins ... & many of us with brilliant sites & >1500 patients, prospective data and a gene hit of direct clinical utility. – at Edinburgh, Scotland
The main treatment for #Crohns disease is a TNF-antibody, but many patients develop an immune response. It turns out that a common HLA allele (40% w/ European ancestry) is tied to this problem gastrojournal.org/article/S0… @AGA_Gastro @AmerGastroAssn #PGX
RAPIDIBD retweeted
BRAVO @PRED4research Tariq & @ClaireBewshea - Not only transforming the pharmacogenetic landscape in #IBD, but also launching a vintage era for IBD research in the UK - collaborative, #bigdata projects - demonstrating what is possible with vision & grit on a shoestring.
3000 patients 👩👩👦, 7 years 🗓️, 9 arms 🧬, 162 sites 🏥 later... thank you to all the patients, research nurses and PIs who have contributed to @pred4research....
RAPIDIBD retweeted
3000 patients 👩👩👦, 7 years 🗓️, 9 arms 🧬, 162 sites 🏥 later... thank you to all the patients, research nurses and PIs who have contributed to @pred4research....













